Collegium Pharmaceutical Inc (COLL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	3.22% 144.92	149.75	136.71	135.55	144.77
Cost Of Revenue	2.99% 53.47	55.12	56.40	61.72	67.36
Gross Profit	3.35% 91.46	94.63	80.31	73.83	77.40
Operating Expenses	27.44% 41.98	32.94	35.30	38.19	52.77
Interest Income/Expense	10.07% 17.34	19.28	20.77	21.86	21.43
Benefits Costs and Expenses	5.11% 108.30	103.03	107.93	117.75	162.32
Costs And Expenses	5.11% 108.30	103.03	107.93	117.75	162.32
Operating Income/Loss	19.80% 49.47	61.69	45.01	35.63	24.63
Income/Loss From Continuing Operations Before Tax	21.60% 36.62	46.71	28.78	17.80	-17.56
Income Tax Expense/Benefit, Deferred	1,205% -4.412	-0.338	-1.133	-0.636	-0.046
Income Tax Expense/Benefit	39.68% 8.909	14.77	8.149	4.79	-0.131
Income/Loss From Continuing Operations After Tax	13.23% 27.71	31.94	20.63	13.01	-17.43
Net Income/Loss	13.23% 27.71	31.94	20.63	13.01	-17.43
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.08% 32.33	32.30	33.74	34.62	34.32
Diluted Average Shares	0.38% 41.44	41.28	42.06	42.85	34.32
Basic Earnings Per Share	13.13% 0.86	0.99	0.61	0.38	-0.51
Diluted Earnings Per Share	13.41% 0.71	0.82	0.53	0.34	-0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ELAN

$12.67

0.88%

LNTH

$114.96

0.42%

ITCI

$89.24

3.56%

CTLT

$58.48

0.36%

NBIX

$121.53

0.83%

VTRS

$11.61

1.40%